Melinta Therapeutics, Llc
Clinical trials sponsored by Melinta Therapeutics, Llc, explained in plain language.
-
New antibiotic dose tested in kids for tough infections
Disease control CompletedThis study tested a single dose of the antibiotic oritavancin in 41 children under 18 with suspected or confirmed bacterial infections. The goal was to find the right dose and check how safe it is. Results help doctors understand how the drug works in kids.
Phase: PHASE1 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated May 26, 2026 14:14 UTC
-
One-shot antibiotic shows promise for kids with skin infections
Disease control CompletedThis study tested a single-dose antibiotic called oritavancin in 118 children aged 3 months to under 12 years with bacterial skin infections. The goal was to see if the drug is safe and tolerable. Researchers compared two versions of the drug and monitored side effects and how we…
Phase: PHASE2 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated May 26, 2026 12:05 UTC